abstract |
The present invention relates to co-crystals of compounds of formula (I), methods for preparing said co-crystals, pharmaceutical compositions thereof, and methods of using said co-crystals for the treatment or prevention of thromboembolic disorders in which The coformer molecule is succinic acid or citric acid. |